This inventor holds 2 USPTO granted patents. Top assignee: Biotica Technology Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Christoph Hendrik Beckmann: Innovator in Medical Chemistry
Introduction
Christoph Hendrik Beckmann is a noteworthy inventor based in Nr Saffron Walden, GB, who has made significant contributions to the field of medical chemistry. With a robust portfolio of two patents, he is dedicated to advancing healthcare solutions through innovative compounds.
Latest Patents
Beckmann's latest patents revolve around the 39-desmethoxy derivatives of rapamycin. His inventions relate to novel derivatives that show promise in various therapeutic areas. The first patent focuses on the utility of these compounds in treating cancer and B-cell malignancies, as well as their application in managing immunosuppression, treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease, fibrotic diseases, and even stimulation of neuronal regeneration and treatment of fungal infections. The second patent reiterates these innovative uses and methods for producing these rapamycin derivatives, underscoring their potential to impact various medical conditions.
Career Highlights
Beckmann is associated with Biotica Technology Limited, a company that underscores the importance of biotechnological innovations. His work there exemplifies a commitment to harnessing cutting-edge research to address healthcare challenges, particularly in oncology and immunology.
Collaborations
Throughout his career, Beckmann has collaborated with esteemed colleagues such as Steven James Moss and Rose Mary Sheridan. These partnerships reflect a collaborative spirit in the pursuit of advancing therapeutic technologies and contribute to the collective success of their initiatives at Biotica Technology Limited.
Conclusion
Christoph Hendrik Beckmann stands as a prominent figure in the arena of medical innovations, particularly in the development of novel therapeutic compounds. His patents on 39-desmethoxy derivatives of rapamycin not only illustrate his inventive prowess but also pave the way for potential breakthroughs in treatment methodologies for serious health conditions. Through his ongoing work and collaborative efforts, Beckmann continues to contribute to the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile